Page 124 - FINAL PROGRAMME 2017
P. 124
16:00 O-169
16:15 O-170
Towards the development of a WHO International Standard for immunoassays of Mullerian Inhibiting Substance/Anti Mullerian Hormone (MIS/AMH)
J. Ferguson1, D. Pepin2, P. Donahoe2, C. Burns1
1National Institute for Biological Standards and Control, Biotherapeutics Division - Endocrinology Section, Potters Bar, United Kingdom
2Massachusetts General Hospital, Pediatric Surgical Research Laboratories, Boston, U.S.A.
Applying data-driven approaches to develop a novel ovarian reserve score that leverages underlying relationships between distinct markers of ovarian reserve
K. Hunter Cohn1, C. Glazner1, L. Tan1, E. Widra2, M. Leondires3, B. Miller4, C. Benadiva5, J. Nulsen5, G. Letterie6, A. Copperman7, P. Yurttas Beim1
1Celmatix Inc, Research and Development, New York, U.S.A.
2Shady Grove Fertility, Reproductive Science Center, Rockville, U.S.A.
3Reproductive Medicine Associates of Connecticut, Fertility Center, Norwalk, U.S.A. 4Reproductive Medicine Associates of Michigan, Fertility Center, Troy, U.S.A.
5The Center for Advanced Reproductive Services, Fertility Center, Farmington, U.S.A. 6Seattle Reproductive Medicine, Fertility Center, Seattle, U.S.A.
7Reproductive Medicine Associates of New York, Fertility Center, New York, U.S.A.
124
